A61K 45 - Medicinal preparations containing active ingredients not provided for in groups

Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
12/2004
12/01/2004	CN1551784A Prostaglandin compositions and methods of treatment for male erectile dysfunction
12/01/2004	CN1551777A Novel virus proliferaton inhibition/virucidal method and novel pyradine nucleotide/pyradine nucleoside analogue
12/01/2004	CN1551772A Inhibition of the growth factor dependency of tumor cells
12/01/2004	CN1551769A Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
12/01/2004	CN1551768A Substituted benzimidazole dosage forms and method of using same
12/01/2004	CN1551767A Cancer treatment
12/01/2004	CN1551766A Lymphocytic activation inhibitor and remedial agent for autoimmune disease
12/01/2004	CN1551763A Novel treatment method
12/01/2004	CN1551760A Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
12/01/2004	CN1550235A Use of heparin-binding antagonists in the inhibition of bradykinin release
12/01/2004	CN1177861C Macrocylic peptides active against the hepatitis V virus
12/01/2004	CN1177614C Slow releasing composition
12/01/2004	CN1177613C Chemokine receptor antagonist and ocyclosporin in combined therapy
12/01/2004	CN1177594C Formulation for use in prevention of pathogen induced diseases including HIV and HSV
12/01/2004	CN1177589C Analgesic combination
11/2004
11/30/2004	US6825350 Administering dosage of immunology response moderator
11/30/2004	US6825329 Human PEM as a target for birth control and treatment of Alzheimer's disease
11/30/2004	US6825234 Compositions and methods for amelioration of human female sexual dysfunction
11/30/2004	US6825229 Administering protein kinase c activators such as macrocyclic lactones (i.e. bryostatin class and neristatin class)
11/30/2004	US6825226 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias
11/30/2004	US6825224 Prodrugs of carbamate inhibitors of IMPDH
11/30/2004	US6825210 5,10-dihydrobenzo(b)(1,8)naphthyridine compounds, n-oxides; 3,7-dichloro-5-isopropoxymethyl-5-trifluoromethyl-5,10 -dihydrobenzo(b)(1,8)naphthyridine for example; combination therapy
11/30/2004	US6825203 Topical anesthetic/opioid formulations and uses thereof
11/30/2004	US6825201 Indole, azaindole and related heterocyclic amidopiperazine derivatives
11/30/2004	US6825198 5-HT receptor ligands and uses thereof
11/30/2004	US6825188 More potent inhibitors of the vitronectin receptor than the fibrinogen
11/30/2004	US6825186 Method and compositions for treating atheroma, tumors and other neoplastic tissue
11/30/2004	US6825185 Improving the cardiovascular profile of a cox-2 selective inhibitor by administering with 3-hydroxy-3- methylglutaryl coenzyme a, an antiplatelet agent, a thrombin inhibitor or a thromboxane inhibitor
11/30/2004	US6825174 Mixture of surfactant and nucleic acids
11/30/2004	US6825008 Expressed ligand—vascular intercellular signalling molecule
11/30/2004	US6825007 Therapeutic and diagnostic methods and compositions based on Jagged/Notch proteins and nucleic acids
11/30/2004	US6824991 Human bad polypeptides, encoding nucleic acids and methods of use
11/30/2004	US6824790 Capsule, tablet with enteric, protective coatings; bioavailability
11/30/2004	US6824786 Topical applying cosmetic
11/30/2004	US6824773 TWEAK receptor
11/30/2004	US6824771 Increased coxsackle-adenovirus receptor (car) expression on tumor cells; modification of viral tropism enhancing tumor transduction and selectivity
11/30/2004	US6824769 Compositions comprise alpha-interferon or a derivative thereof and an inosine monophosphate dehydrogenase inhibitor; hepatitis virus
11/30/2004	US6824761 Anti-asthmatic combinations comprising surface active phospholipids
11/30/2004	CA2298245C Matrix controlled release device
11/30/2004	CA2265461C Compositions and methods for topical application of therapeutic agents
11/30/2004	CA2134680C Tissue-specific implantable therapeutic agent delivery system
11/27/2004	CA2467410A1 Method for treatment of glaucoma and ocular hypertension with prostaglandin analgoues without melanogenic side-effect
11/27/2004	CA2464379A1 Use of anti-glaucoma drugs to treat visual defects associated with the use of a gabaergic agent
11/25/2004	WO2004101764A2 Methods of modulating metastasis and skeletal related events resulting from metastases
11/25/2004	WO2004101535A1 Pharmaceutical composition comprising valsartan
11/25/2004	WO2004100992A2 Therapeutic combinations of atypical antipsychotics with gaba modulators, anticonvulsants or benzodiazapines
11/25/2004	WO2004100991A1 Use of endothelin-1 antagonists for improving cancer therapy
11/25/2004	WO2004100981A1 One or several enzyme-containing compounds, dietetic food products and drugs produced from said compounds and the use therefor for medical purposes
11/25/2004	WO2004100939A1 Combination of the analeptic modafinil and an antidepressant for the treatment of depression
11/25/2004	WO2004100938A1 Combination of the analeptic modafinil and an antidepressant for the treatment of depression
11/25/2004	WO2004100899A2 Use of secretin in treatments of disorders associated with the amygdala
11/25/2004	WO2004100896A2 Anti-aging nutritional supplement
11/25/2004	WO2004100879A2 Method and composition for preventing or reducing edema, deep vein thrombosis and/or pulmonary embolism
11/25/2004	WO2004100867A2 Method and kit for regulation of microvascular tone
11/25/2004	WO2004100826A2 Dietary supplement and method for the treatment and prevention of digestive tract ulcers in equines and other animals
11/25/2004	WO2004087167A3 Pharmaceutical compositions comprising epinastine for the treatment of skin diseases
11/25/2004	WO2004087094A3 Nano-sized vehicles transporting a therapeutic agent and at least one drug resistance modulator for the treatment of multi drug resistance
11/25/2004	WO2004067002A3 SELECTIVE mGlu5 ANTAGONISTS FOR TREATMENT OF NEUROMUSCULAR DYSFUNCTION OF THE LOWER URINARY TRACT
11/25/2004	WO2004064889A3 Intradermal cellular delivery using narrow gauge micro-cannula
11/25/2004	WO2004064738A3 Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases
11/25/2004	WO2003090599A3 Methods and apparatus for modifying properties of the bbb and cerebral circulation by using the neuroexcitatory and/or neuroinhibitory effects of odorants on nerves in the head
11/25/2004	WO2003086280A3 Immunostimulatory g,u-containing oligoribonucleotides
11/25/2004	US20040236413 Stents with vitronectin receptor antagonists against restenosis
11/25/2004	US20040236407 Methods and apparatus for stenting comprising enhanced embolic protection coupled with improved protections against restenosis and thrombus formation
11/25/2004	US20040236102 Enzyme inhibitor for treating a non-insulin dependent diabetes mellitus; 3-Amino-4-(3,4-difluorophenyl)butanoyl]-4-[2-({3-[(methylsulfonyl)amino]-phenyl}-amino)-2-oxoethyl]piperazin-2-yl}acetic acid
11/25/2004	US20040235950 Administering, topically or systemically, an inhibitor of the matrix degrading enzymes and a cytokine inhibitor that alleviates inflammation and also alleviate neutrophil infiltration
11/25/2004	US20040235945 Combining EDTA-sodium-metal complex(es) and the sodium selenite solution to from trace element soultuton to provide the solution to the animals
11/25/2004	US20040235925 preventing a cyclooxygenase-2 mediated disorder
11/25/2004	US20040235923 mixture of threonine, proline, glycine, valine, isoleucine, leucine, tyrosine, phenylalanine, lysine, aspartic acid, serine, glutamic acid, alanine, methionine, histidine and arginine as a unit; reduction of accumulated body fat, alleviation of excess sensitivity to cold, warming of a cold body
11/25/2004	US20040235919 Useful in treating cell proliferative disorders associated with an altered cell cycle dependent kinase activity; cancer, Alzheimer's disease, viral infections, auto-immune diseases and neurodegenerative disorders
11/25/2004	US20040235907 Treatment of diabetes and related pathologies
11/25/2004	US20040235881 Immune response modifiers for the treatment of periodontal disease
11/25/2004	US20040235866 Lymphocytic activation inhibitor and remedial agent for autoimmune disease
11/25/2004	US20040235864 Jun kinase inhibitors
11/25/2004	US20040235863 As stimulators for soluble guanylate cyclase and to their use as agents in the therapy of cardiovascular diseases, hypertonicity, thrombo-embolic diseases and ischemia, sexual dysfunction or inflammations and for the treatment of diseases of the central nervous system
11/25/2004	US20040235860 Administering therapeutically effective amount of a carbostyril derivative compound for therapy of nervous system disorders
11/25/2004	US20040235823 Administering compounds such as N-(2-pyridinylmethyl)-N'-(6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl)-1,4-benzenedimethanamine for therapy of disease mediated by a chemokine receptor
11/25/2004	US20040235809 Epoxy steroidal aldosterone antagonist and beta-adremergic antagonist combination therepy for treatment of congestive heart failure
11/25/2004	US20040235808 Administering compounds such as 17 beta -[4-(dimethylamino)-benzoyloxy]-androst-4-en-3-one for modulating a function mediated by the androgen receptor in a tissue selective manner
11/25/2004	US20040235807 Administering formulation for intranasal drug administration, wherein the formulation comprises: a topically administrable decongestant;a topically administrable corticosteroid: and carrier that is suitable for nasal drug administration
11/25/2004	US20040235803 Dispersible formulation of an anti-inflammatory agent
11/25/2004	US20040235802 Combinations comprising cox-2-inhibitors and aspirin
11/25/2004	US20040235801 Therapy for stroke
11/25/2004	US20040235799 Use of a compound with a negatively charged domain of radicals for the treatment of restenosis
11/25/2004	US20040235797 Methods for identifying compounds useful for inhibiting farnesyl diphosphate synthase
11/25/2004	US20040235796 For therapy of proliferative disease
11/25/2004	US20040235795 Administration of an agent produced from phosphatidylserine (PS), lyso-phosphatidylserine or/and a physiologically acceptable salt thereof in combination with additive selected from a group comprising antioxidants, essential fatty acids, mineral substances, amino acids, mood-lifters, phospholipids
11/25/2004	US20040235785 Potentiator of antitumoral agents in the treatment of cancer
11/25/2004	US20040235784 Combination preparations of 3-n-formylhydroxylaminopropyl phosphonic acid derivatives or 3-n-acetylhydroxylaminopropyl phosphonic acid derivatives combined with specific pharmaceutical active agents
11/25/2004	US20040235783 Pharmaceutical compositions for the treatment of tumor diseases
11/25/2004	US20040235781 Pharmaceutical composition of antiviral agents
11/25/2004	US20040235780 Pharmaceutical composition of antiviral agents
11/25/2004	US20040235779 Synergistic mixture of tipranavir and 3'-deoxy-3'-fluorothymidine, -cytosine, -adenosine, and/or guanosine type derivatives; human T-cell leukemia/lymphoma virus, lymphadenopathy associated virus; AIDS
11/25/2004	US20040235778 Methods for regulating hematopoiesis using CpG-oligonucleotides
11/25/2004	US20040235777 Enhancing immune response to cancer antigen comprising by administering a CpG (cytosine-phosphate diester-guanine) oligonucleotide; thrombopoiesis, anemia
11/25/2004	US20040235776 Use of inhibitors for the treatment of RTK-hyperfunction-induced disorders, particularly cancer
11/25/2004	US20040235761 Novel virus proliferaton inhibition/virucidal method and novel pyradine nucleotide/pyradine nucleoside analogue
11/25/2004	US20040235759 Increasing acute or chronic injection-site toleration in mammals by administering single dose descladinose azalide derivative mixture
11/25/2004	US20040235757 Anticarcinogenic and antimetastasis agents; leukemia or Hodgkin's disease.
11/25/2004	US20040235755 Modulating glycolysis enzyme complex/M2-PK and/or by inhibiting transaminases and/or separating the binding of the mitochondrial malate dehydrogenase to p36 protein

1 ... 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 ... 1151